Added to YB: 2025-06-09
Pitch date: 2025-06-05
CRMD [bullish]
CorMedix Inc.
-15.53%
current return
Author Info
No bio for this author
Company Info
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.
Market Cap
$865.8M
Pitch Price
$13.39
Price Target
N/A
Dividend
N/A
EV/EBITDA
13.49
P/E
13.96
EV/Sales
5.56
Sector
Pharmaceuticals
Category
growth
The 10 Bagger - CorMedix (CRMD)
CRMD: DefenCath, FDA-approved catheter lock solution w/ taurolidine, reduces catheter-related bloodstream infections by 71%. TAM 170k patients, contracts covering 70% of market. Worst case: $1.8B terminal value at 10% penetration (10k patients) & severe price erosion ($50/vial). TDAPA phase started July 2024, RWE data due next month.
Read full article (8 min)